Low-Dose Aspirin and Medical Record–Confirmed Age-related Macular Degeneration in a Randomized Trial of Women
- 7 October 2009
- journal article
- research article
- Published by Elsevier BV in Ophthalmology
- Vol. 116 (12), 2386-2392
- https://doi.org/10.1016/j.ophtha.2009.05.031
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (CA47988, EY06633, HL43851)
This publication has 55 references indexed in Scilit:
- Is early age-related macular degeneration related to carotid artery stiffness? The Atherosclerosis Risk in Communities StudyBritish Journal of Ophthalmology, 2006
- Ranibizumab for Neovascular Age-Related Macular DegenerationNew England Journal of Medicine, 2006
- Low-Dose Aspirin in the Primary Prevention of CancerJama-Journal Of The American Medical Association, 2005
- Is medication use associated with the incidence of early age-related maculopathy?*1Pooled findings from 3 continentsOphthalmology, 2004
- Aspirin Protects Endothelial Cells From Oxidant Damage Via the Nitric Oxide-cGMP PathwayArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsBMJ, 2002
- Final Report on the Aspirin Component of the Ongoing Physicians' Health StudyNew England Journal of Medicine, 1989
- Macular Hemorrhage in the Aging Eye: the Effects of AnticoagulantsNew England Journal of Medicine, 1988
- The iron-binding and hydroxyl radical scavenging action of anti-inflammatory drugsXenobiotica, 1988
- Inhibition of platelet prostaglandin synthetase by oral aspirin.JCI Insight, 1978